128 related articles for article (PubMed ID: 3392237)
1. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
Johnson BF; Haffajee CI; Woodman T; Sloan KL
J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacokinetics of oral pirmenol.
Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
[TBL] [Abstract][Full Text] [Related]
4. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics.
Hammill SC; Shand DG; Routledge PA; Hindman MC; Baker JT; Pritchett EL
Circulation; 1982 Feb; 65(2):369-75. PubMed ID: 7053896
[TBL] [Abstract][Full Text] [Related]
5. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.
Hampton EM; Anderson JL; Lutz JR; Nappi JM
Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology and pharmacokinetics of pirmenol.
Reiter MJ
Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
[TBL] [Abstract][Full Text] [Related]
9. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study.
Anderson JL; Lutz JR; Nappi JM
Am J Cardiol; 1984 Feb; 53(4):522-7. PubMed ID: 6198894
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic efficacy of pirmenol in the treatment of premature ventricular complexes.
Toivonen LK; Nieminen MS; Manninen V; Frick MH
Eur Heart J; 1985 Sep; 6(9):737-44. PubMed ID: 2416566
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
12. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
Salerno DM; Fifield J; Farmer C; Hodges M
Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
[TBL] [Abstract][Full Text] [Related]
14. Preliminary study of pirmenol in the treatment of ventricular arrhythmias.
Gimeno Gascon JV; Algarra Vidal FJ
Am J Cardiol; 1987 Jun; 59(16):53H. PubMed ID: 3591713
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical pharmacokinetics of pirmenol.
Chang T
Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922
[TBL] [Abstract][Full Text] [Related]
16. Pirmenol in the long-term treatment of chronic ventricular arrhythmias: a placebo-controlled study.
Toivonen LK; Nieminen MS; Manninen V; Frick MH
J Cardiovasc Pharmacol; 1986; 8(1):156-60. PubMed ID: 2419679
[TBL] [Abstract][Full Text] [Related]
17. A multicenter dose-response study of pirmenol hydrochloride in patients with ventricular premature contractions.
Farnham DJ
Am J Cardiol; 1987 Jun; 59(16):43H-47H. PubMed ID: 2438923
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractions.
Janiczek N; Smith DE; Chang T; Sedman AJ; Stringer KA
J Clin Pharmacol; 1997 Jun; 37(6):502-13. PubMed ID: 9208357
[TBL] [Abstract][Full Text] [Related]
19. Use of flecainide acetate in the treatment of premature ventricular contractions.
Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
[TBL] [Abstract][Full Text] [Related]
20. Pirmenol kinetics and effective oral dose.
Hammill SC; Shand DG; Harrell FE; Zimmerman JM; Reiter MJ; Verghese C; Pritchett EL
Clin Pharmacol Ther; 1982 Dec; 32(6):686-91. PubMed ID: 7140134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
